J&J, AstraZeneca Explore Covid-19 Vaccine Modification

The University of Oxford, Johnson & Johnson and AstraZeneca are conducting early-stage research into whether potential modifications of their vaccines could reduce or eliminate the risk of rare but serious blood clots associated with the shots, according to people close to the process.

Apple, Amazon, Tesla Set to Post Results

More than a third of the S&P 500—including McDonald’s, Ford and...

Chicago Casino Would Be Costly, Gambling Operators Say

Chicago is hoping a megacasino will aid its underfunded pensions but...

Social-Media Manager, the Most Millennial Job, Comes of Age

Some social-media veterans have been doing their jobs for 15 years...

The Boss Wants You Back in the Office. Like, Now.

Companies are starting to summon workers back, though many employees have...